The receptor and transporter for internalization of Clostridium botulinum type C progenitor toxin into HT-29 cells

Biochemical and Biophysical Research Communications

Volumn 319, Issue 2, 2004, Pages 327-333

  Nishikawa, Atsushi ^a,e   Uotsu, Nobuo ^a   Arimitsu, Hideyuki ^b   Lee, Jae Chul ^b   Miura, Yutaka ^a   Fujinaga, Yukako ^b,f   Nakada, Hiroshi ^c   Watanabe, Toshihiro ^d   Ohyama, Tohru ^d   Sakano, Yoshiyuki ^a   Oguma, Keiji ^b  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c KYOTO SANGYO UNIVERSITY   (Japan)

^d TOKYO UNIVERSITY OF AGRICULTURE   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^f Japan Science and Technology Agency   (Japan)

Author keywords

Clostridium botulinum; Endocytic mechanisms; Hemagglutinin; Mucin; O linked oligosaccharide; Toxin binding

Indexed keywords

BENZYL 2 ACETOAMIDE 2 DEOXY ALPHA DEXTRO GALACTOPYRANOSIDE; BOTULINUM TOXIN; BOTULINUM TOXIN C; DEXTRO THREO 1 PHENYL 2 HEXADECANOYLAMINO 3 MORPHOLINOPROPANOL; GANGLIOSIDE; PROPANOL; PYRANOSIDE; RECEPTOR; SIALIDASE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CARCINOMA CELL; CELL SURFACE; CLOSTRIDIUM BOTULINUM; COLON CARCINOMA; CONTROLLED STUDY; ENDOCYTOSIS; GLYCOSYLATION; HUMAN; HUMAN CELL; INTERNALIZATION; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN BINDING;

BOTULINUM TOXINS; GLYCOSYLATION; HT29 CELLS; HUMANS; MICROSCOPY, FLUORESCENCE; NEURAMINIDASE; PROTEIN BINDING; PROTEIN TRANSPORT;

CLOSTRIDIUM; CLOSTRIDIUM BOTULINUM;

EID: 2642530185     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.04.183     Document Type: Article

References (26)

1. Fujinaga Y., Inoue K., Shimazaki S., Tomochika K., Tsuzuki K., Fujii N., Watanabe T., Ohyama T., Takeshi K., Inoue K., Oguma K. Molecular construction of Clostridium botulinum type C progenitor toxin and its gene organization. Biochem. Biophys. Res. Commun. 205:1994;1291-1298
2. Watanabe T., Sagane Y., Kouguchi H., Sunagawa H., Inoue K., Fujinaga Y., Oguma K., Ohyama T. Molecular composition of progenitor toxin produced by Clostridium botulinum type C strain 6813. J. Protein Chem. 18:1999;753-760
3. Inoue K., Fujinaga Y., Honke K., Yokota K., Ikeda T., Ohyama T., Takeshi K., Watanabe T., Inoue K., Oguma K. Characterization of haemagglutinin activity of Clostridium botulinum type C and D 16S toxins, and one subcomponent of haemagglutinin (HA1). Microbiology. 145:1999;2533-2542
4. Kouguchi H., Watanabe T., Sagane Y., Ohyama T. Characterization and reconstitution of functional hemagglutinin of the Clostridium botulinum type C progenitor toxin. Eur. J. Biochem. 268:2001;4019-4026
5. Nishiki T., Kamata Y., Nemoto Y., Omori A., Ito T., Takahashi M., Kozaki S. Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes. J. Biol. Chem. 269:1994;10498-10503
6. Kozaki S., Kamata Y., Watarai S., Nishiki T., Mochida S. Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins. Microb. Pathog. 25:1998;91-99
7. Herreros J., Schiavo G. Lipid microdomains are involved in neurospecific binding and internalisation of clostridial neurotoxins. Int. J. Med. Microbiol. 291:2002;447-453
8. Yolken R., Peterson J., Vonderfecht S., Fouts E., Midthun K., Newburg D. Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis. J. Clin. Invest. 90:1992;1984-1991
9. Walters R.W., Pilewski J.M., Chiorini J.A., Zabner J. Secreted and transmembrane mucins inhibit gene transfer with AAV4 more efficiently than AAV5. J. Biol. Chem. 277:2002;23709-23713
10. Jentoft N. Why are proteins O-glycosylated? Trends Biochem. Sci. 15:1990;291-294
11. Bansil R., Stanley E., Lamont J.T. Mucin biophysics. Annu. Rev. Physiol. 57:1995;635-657
12. Maksymowych A.B., Reinhard M., Malizio C.J., Goodnough M.C., Johnson E.A., Simpson L.L. Pure botulinum neurotoxin is absorbed from the stomach and small intestine and produces peripheral neuromuscular blockade. Infect. Immun. 67:1999;4708-4712
13. Fujinaga Y., Inoue K., Watanabe S., Yokota K., Hirai Y., Nagamachi E., Oguma K. The haemagglutinin of Clostridium botulinum type C progenitor toxin plays an essential role in binding of toxin to the epithelial cells of guinea pig small intestine, leading to the efficient absorption of the toxin. Microbiology. 143:1997;3841-3847
14. Pimental R.A., Julian J., Gendler S.J., Carson D.D. Synthesis and intracellular trafficking of Muc-1 and mucins by polarized mouse uterine epithelial cells. J. Biol. Chem. 271:1996;28128-28137
15. Altschuler Y., Kinlough C.L., Poland P.A., Bruns J.B., Apodaca G., Weisz O.A., Hughey R.P. Clathrin-mediated endocytosis of MUC1 is modulated by its glycosylation state. Mol. Biol. Cell. 11:2000;819-831
16. Lesuffleur T., Porchet N., Aubert J., Swallow D., Gum J., Kim Y., Real F., Zweibaum A. Differential expression of the human mucin genes MUC1 to MUC5 in relation to growth and differentiation of different mucus-secreting HT-29 cell subpopulations. J. Cell Sci. 106:1993;771-783
17. Huet G., Kim L., de Bolos C., Lo-Guidice J.M., Moreau O., Hemon B., Richet C., Delannoy P., Real F.X., Degand P. Characterization of mucins and proteoglycans synthesized by a mucin-secreting HT-29 cell subpopulation. J. Cell Sci. 108:1995;1275-1285
18. Sheehan J.K., Brazeau C., Kutay S., Pigeon H., Kirkham S., Howard M., Thornton D.J. Physical characterization of the MUC5AC mucin: a highly oligomeric glycoprotein whether isolated from cell culture or in vivo from respiratory mucous secretions. Biochem. J. 347:2000;37-44
19. Truant S., Bruyneel E., Gouyer V., Wever O.D., Pruvot F.-R., Mareel M., Huet G. Requirement of both mucins and proteoglycans in cell-cell dissociation and invasiveness of colon carcinoma HT-29 cells. Int. J. Cancer. 104:2003;683-694
20. Oguma K., Syuto B., Iida H., Kubo S. Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains. Infect. Immun. 30:1980;656-660
21. Mahmut N., Inoue K., Fujinaga Y., Hughes L., Arimitsu H., Sakaguchi Y., Ohtsuka A., Murakami T., Yokota K., Oguma K. J. Med. Microbiol. 51:2002;286-294
22. Kuan S., Byrd J., Basbaum C., Kim Y. Inhibition of mucin glycosylation by aryl-N-acetyl-alpha-galactosaminides in human colon cancer cells. J. Biol. Chem. 264:1989;19271-19277
23. Yowler B.C., Kensinger R.D., Schengrund C.-L. Botulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I. J. Biol. Chem. 277:2002;32815-32819
24. Li L., Singh B. Isolation of synaptotagmin as a receptor for types A and E botulinum neurotoxin and analysis of their comparative binding using a new microtiter plate assay. J. Nat. Toxins. 7:1998;215-263
25. Sandvig K., Deurs B.v. Membrane traffic exploited by protein toxins. Annu. Rev. Cell Dev. Biol. 18:2002;1-24
26. Pallesen L.T., Berglund L., Rasmussen L.K., Petersen T.E., Rasmussen J.T. Isolation and characterization of MUC15, a novel cell membrane-associated mucin. Eur. J. Biochem. 269:2002;2755-2763